about
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.Preliminary experience with 4K ultra-high definition endoscope: analysis of pros and cons in skull base surgery.A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome.Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.Skin glomic tumors referred for local pain and cured by surgical removal.Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii.Olfactory groove meningioma: report of 99 cases surgically treated at the Catholic University School of Medicine, Rome.Is deferred use of bevacizumab for glioblastoma associated with prolonged survival?Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.Communicating hydrocephalus following surgery and adjuvant radiochemotherapy for glioblastoma.Persistence of primary empty sella syndrome despite obesity surgery: report of two unusual cases.Neuroendoscopic Treatment of Cystic Craniopharyngiomas: A Case Series with Systematic Review of the Literature.12-year-old boy with multiple brain masses.Response to: "rare serious complications of erlotinib therapy".VEGF isoforms as outcome biomarker for anti-angiogenic therapy in recurrent glioblastoma.Decompressive hemicraniectomy: dissociation between clinical and radiological findings.Calcified extra-axial cavernoma involving lower cranial nerves: technical case report.Morphological and functional MR imaging of Lhermitte-Duclos disease with pathology correlate.Ulnar nerve entrapment at the elbow. A surgical series and a systematic review of the literature.The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.Acute brainstem compression.VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case reportXanthogranuloma of the sellar region: A rare tumor. Case illustration and literature reviewGlioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosisInfluence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cordUltrasound evaluation in traumatic peripheral nerve lesions: from diagnosis to surgical planning and follow-upLetter to the editor. Cytochemical CSF analysis and antibiotic-impregnated external ventricular drainsLetter to the Editor: Ultrasound in peripheral nerve injuries: the challengeEndothelial trans-differentiation in glioblastoma recurring after radiotherapyO-arm in Endonasal Endoscopic Cranial Base Surgery: Technical Note on Initial FeasibilityOrbital Tumors: Report of 70 Surgically Treated CasesSurgical case of subacute headache in a young Latin American woman
P50
Q33274834-5F85263B-7B03-4B24-9035-C61B81651148Q33777005-81C492B3-4BF8-44F2-87F2-801DCC6C1177Q35547649-D5EEB913-E993-4DBE-9FE1-2825BFBA721CQ36560256-BAC9F9FA-73B3-4DD3-AA87-0893BD59462CQ37692723-3E92542E-4369-43DA-9DB6-430F70E820CDQ37706584-149FC823-6030-4D1B-9D73-BEDAB0E798AAQ38659033-83E00114-920F-4627-A59E-684190C1D512Q38743424-5B97CFE1-10FB-4269-BF58-10050EDBFD44Q38829699-FE4B7044-E530-4B67-B82F-1143798848F1Q38935921-A3D88DC4-3C46-4A12-9BBB-EC29CA3D33DBQ39357751-A54D0D83-5EB6-4106-AB7A-B32F14424471Q40569983-7D48C65F-4016-4919-B1CC-D661B018365CQ42469593-85A18B41-6397-4214-86B6-116FEEF2A52AQ42880814-AC8DE271-4F63-42B9-8FF6-8F3C7A309B5AQ45281150-DDDD20D0-937B-47F8-B0F5-897C3CA19F23Q47267328-CA81E4A5-D025-458C-BFFE-0E9F6954D409Q47587386-92FF6787-ED47-42A9-AF4C-39E0DDC82F30Q47605421-0E47BC1D-E304-4252-B17C-93703289246AQ48176969-72BA2780-0908-4A84-BBFE-1F437F5B969EQ48232654-EC3B229C-9B9A-4308-AE06-6E5949EB5F3CQ48235625-7FE80EC7-F0D0-4518-A7AB-BB1D13663701Q48609713-89DAD764-46D0-478C-9CE9-8F108437F9F9Q48722170-46612CA7-8101-4F10-A1E0-B3BB885B8AE1Q48984121-99BB215E-16D8-4FF5-8531-BBDA2D4B4E1AQ50178379-CB495832-9EB7-4492-8C5B-9BFBE24395F8Q53750643-939E755D-6042-4701-972E-FE09DCD0F6F7Q54244725-28DBCC2C-6FE5-4883-8B54-F910B72E3040Q55064617-2A707C6C-59AD-42AD-9C80-1359434EFD5AQ57279492-01010097-09D1-4F3E-9FA9-0219EB15BEBFQ57468804-86EB4F67-6F8D-4677-A961-F34929EA1FEFQ58556522-76B627B2-8760-491E-8358-D2FC9D02ECEEQ58799521-79EDDBB5-B1A6-4BED-95E2-2C2FD143C1A3Q61788268-B3706E66-DC51-41EA-A99C-72F4E41599D0Q86078229-20145E1E-0072-46FE-96AD-6B16CB9C4135Q87639633-F4EDA6F2-307E-4D7D-89C7-6AD44EF47641Q87660216-FC35FD33-C471-4D9B-8D07-7178F6CAB9DFQ88524945-A0476971-D43F-45DC-9E08-D1CF18264870Q89104605-F6152331-3D41-4FFD-87A5-165110D4EA78Q90714162-9FCB46EB-0723-4915-A801-91B277380087Q91522104-C91A5D39-875E-4844-943B-1FE7A026C90E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Quintino Giorgio D'Alessandris
@ast
Quintino Giorgio D'Alessandris
@en
Quintino Giorgio D'Alessandris
@es
Quintino Giorgio D'Alessandris
@nl
Quintino Giorgio D'Alessandris
@sl
type
label
Quintino Giorgio D'Alessandris
@ast
Quintino Giorgio D'Alessandris
@en
Quintino Giorgio D'Alessandris
@es
Quintino Giorgio D'Alessandris
@nl
Quintino Giorgio D'Alessandris
@sl
prefLabel
Quintino Giorgio D'Alessandris
@ast
Quintino Giorgio D'Alessandris
@en
Quintino Giorgio D'Alessandris
@es
Quintino Giorgio D'Alessandris
@nl
Quintino Giorgio D'Alessandris
@sl
P106
P1153
14051448800
P31
P496
0000-0002-2953-9291